Table 1.
Demographic and clinical characteristics.
| Clinical data | SARS-CoV-2 PCR positive at deliverya (N = 18) | SARS-CoV-2 PCR negative at deliverya (N = 9) | Control (N = 11) | p-value |
|---|---|---|---|---|
| Age; years (mean ± SD) | 29.9 ± 6.9 | 31.8 ± 2.8 | 34.9 ± 5.5 | |
| BMI (mean ± SD) | 23.4 ± 3.5 | 27.2 ± 7.3 | 21.7 ± 2.1 | |
| Comorbidities (N) | 0 | 0 | 0 | |
| Gestational period of infection; weeks (mean ± SD) | 39.2 ± 1.6 | 22.2 ± 3.5 | – | 0.012c |
| Severity of infection (N) | Severeb: 2 | Severeb: 0 | – | 0.54d |
| Mild: 16 | Mild: 9 | |||
| Gestational period of delivery; weeks (mean ± SD) | 39.2 ± 1.8 | 38.9 ± 2.1 | 39.5 ± 2.7 | |
| Hyperpyrexia and/or dyspnea (N) | 18 | 0 | – | 2.1 × 10−7d |
| Weight of fetus at birth; g (mean ± SD) | 3353.6 ± 445.3 | 3192.2 ± 423.8 | 3343.6 ± 230.4 | 1vs2 0.35c |
| 1vs3 0.56c | ||||
| 2vs30.36c | ||||
| Apgar 5 min (mean ± SD) | 9.9 ± 0.2 | 10.0 ± 0.0 | 9.9 ± 1.3 | 1vs2 0.95c |
| 1vs3 0.98c | ||||
| 2vs30.96c | ||||
| Newborn gender (Male; Female) | Male:61 | Male:22 | Male:53 | 1vs2 0.68d |
| Female:6 | 1vs3 0.69d | |||
| Female:12 | Female:7 | 2vs30.37d | ||
| Newborn swab result (N) | Positive: 0 | Positive: 0 | – | 1d |
| Negative: 18 | Negative: 9 |
a
Swab results at delivery.
b
intensive care units for supportive cares.
c
Mann-Whitney U test.
d
Fisher exact test.